Psoriasis affects approximately 2-3% of the world‘s population and is an autoimmune disease and a chronic inflammatory skin disease as a serious global problem. As first-line treatment for psoriasis, corticosteroids often possess serious long-term side effects. Therefore, the most urgent need for psoriasis therapy is developing drugs for long-term use with high efficacy and little side effects. PTB323X, a new botanical drug for the treatment of psoriasis, is developed by the Botanical Drug Technology Division of the Industrial Research Institute. In addition to effectively improving the symptoms of psoriasiform dermatitis in animals, the efficacy of PTB323X is superior to vitamin D derivative and has no skin-related side effect during the experimental period.

Artificial intelligence and adaptive therapy combine to create Adaptive Intelligence. Technology will inspire you to reimagine how you’re able to treat each patient in your

Designed for next-generation proton therapy in a smaller footprint.

Patients with severe infectious disease usually lack of appropriate timely treatment be cause of “low positive rate” and “long turn-around time” in conventional clinical test.
Metagenomic next-generation sequencing (mNGS) is a new pathogen detection method provide “Comprehensive”, “Precise” and “Fast” clinical data in one single test. mNGS could help physicians to adjust the medications of anti-infective agents timely and improve the quality of healthcare for patients.

The role of gut microbiota both in human health and in disease has been the subject of intense investigation in last decades. Our team has established a banana resistant starch-based encapsulation platform, named EncapTa, for delivering large number of beneficial bacterial or bioactive materials successfully to the gastrointestinal tract. The EncapTa is a powerful technique for pharmaceuticals and supplements application.

Mobisnet Technology has over 17 years of experience in Long-term healthcare and over 5 years of experience in robot software development. Mobisnet is now the sole distributor of robot temi in Taiwan. With the healthcare software, temi has become an extraordinary helper in the hospitals and nursing homes.

The current practice of blood culture for pathogen detection is still limited to low positive rate (<20%) and time consuming, which can cause diagnostic and treatment delays [1]. Our patented DevinTM blood fractionation membrane enables pathogen enrichment from blood within 5 minutes. PaRTI-SeqTM system incorporates DevinTM blood fractionation membrane and nanopore sequencing technology in order to detect pathogen rapidly (within 8 hours). This system increases the sensitivity of pathogen detection with the highest amount of microbial DNA recovery as compared to other methods.

Cold Spring Biotech makes life better through the automation of precision medicine

Cold Spring Biotech provides you with professional solutions. Microbial nucleic acid preservation, microorganism cultivation and microbiome analysis.

The precision medicine and testing research technology center has been established in Taiwan, and the cutting-edge laboratory has successfully developed its own innovative technology platform, LDTs and IVD products, and provided technical services, solutions and project cooperation.

Lack of appropriate diagnostic tools for telemedicine and home care? Kaohsiung municipal siaogang hospital and SpectroChip Company (SKB) jointly developed a multi-functional micro-spectrometer to reduce the size of a large examination machine suitable for telemedicine and home care.

Severe dyskalemias are common causes of sudden cardiac death. Prompt recognition and rapid correction of these potassium derangements effectively prevent catastrophic outcomes. The ECG12Net, a deep learning model, can estimate potassium concentration via ECG.

JW Diagnostics Inc. provides comprehensive and high-quality tests and molecular analysis services for precision medicine in the fields of preventive health management, maternal and child care, and medical decision-making for cancer therapies, by cooperating with Taipei Medical University.

LuminX dedicates to accelerate the optimization of cell-therapy-products through specific understanding of therapeutic cells distribution in-vivo, long-term viability, as well as their biological fate either in preclinical or clinical setting, and our technologies can transition a potential therapy from the research stage to advanced clinical and commercial applications to save lives.

GeneReach developed POCKIT™ Central Nucleic Acid Analyzer based on automatic extraction system and iiPCR technology. Only 85 minutes from sample to answer for up to 8 samples, which is one of the leading systems around the world.

In 2019, there were about 20 million people around the world who dead from bacterial infections, and 3 million of them dead from antibiotic resistance. The World Health Organization is predicting that 10 million people would died from antibiotic resistance in 2050. Our AI model can now help to identify antimicrobial resistance and provide the right treatment promptly.
By combining MALDI-TOF techniques and AI algorithms, total waiting time to identify antimicrobial resistance is shorten by 24 hours and doctors can prescribe the right antibiotic quickly.